RBFC
Roman Butler Fullerton & Co Portfolio holdings
AUM
$339M
This Quarter Return
+13.76%
1 Year Return
+24.9%
3 Year Return
+114.14%
5 Year Return
+206.87%
10 Year Return
–
AUM
$143M
AUM Growth
+$143M
(+22%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
12.08%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
189
New
30
Increased
87
Reduced
49
Closed
15
Top Buys
| 1 |
Mastercard
MA
|
$4M |
| 2 |
SPDR Dow Jones Industrial Average ETF Trust
DIA
|
$3.48M |
| 3 |
iShares Preferred and Income Securities ETF
PFF
|
$1.06M |
| 4 |
ARK Innovation ETF
ARKK
|
$822K |
| 5 |
Vanguard Dividend Appreciation ETF
VIG
|
$790K |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$885K |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
$863K |
| 3 |
Novartis
NVS
|
$856K |
| 4 |
BEAT
BioTelemetry, Inc.
BEAT
|
$704K |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
$556K |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Healthcare | 11.82% |
| 3 | Financials | 10.15% |
| 4 | Communication Services | 8.47% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHK
176
PIMCO High Income Fund
PHK
$851M
| – | – | -14,640 | Closed | -$123K |
|
177
Qualcomm
QCOM
$173B
| – | – | -8,774 | Closed | -$498K |
|
178
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – | -1,095 | Closed | -$447K |
|
179
Spotify
SPOT
$140B
| – | – | -1,900 | Closed | -$235K |
|
180
Liberty All-Star Equity Fund
USA
$1.95B
| – | – | -23,633 | Closed | -$134K |
|
181
Vertex Pharmaceuticals
VRTX
$100B
| – | – | -2,405 | Closed | -$447K |
|
182
Zoetis
ZTS
$69.3B
| – | – | -2,632 | Closed | -$226K |
|
|
APU
183
DELISTED
AmeriGas Partners, L.P.
APU
| – | – | -18,813 | Closed | -$556K |
|
|
BEAT
184
DELISTED
BioTelemetry, Inc.
BEAT
| – | – | -10,485 | Closed | -$704K |
|
185
CME Group
CME
$96B
| – | – | -2,771 | Closed | -$498K |
|
186
iShares US Healthcare Providers ETF
IHF
$793M
| – | – | -1,606 | Closed | -$271K |
|
|
MHF
187
Western Asset Municipal High Income Fund
MHF
$151M
| – | – | -10,270 | Closed | -$73K |
|
|
188
Novartis
NVS
$245B
| – | – | -9,721 | Closed | -$856K |
|